Learning from Real Life Data – highlights of the national ABCD programme
Summarise findings from ABCD nationwide audit programme of new diabetes therapies and devices from over the last 10 years (including GLP-1 receptor agonists, SGLT2 inhibitors, insulin Degludec, FreeStyle Libre). Highlight the differences between data from clinical trials and that from real world experience to show how much more we learn.
- Understand how the learning from real-life data from the ABCD audit programme, over and above the information in the clinical trials, has helped clinical practice
- Learn what the current audits and planned audits are, what we might learn from them and how to take part, whether as a Consultant, Trainee, General Practitioner, Diabetes Specialist Nurse or Practice Nurse
- Learn how easy it is to use the online tool to analyse your own data
- Learn how the audit programme has helped us understand safety issues with regards to new medications, as well as efficacy
Tuesday 29 October 2019
10:10 - 10:50